Breckenridge has entered into an agreement with Pharmaceutics International to develop and manufacture a generic HRT product.
Subscribe to our email newsletter
Breckenridge filed an ANDA with the FDA in early 2006 and expects to receive FDA Approval and market the product in 2007.
Breckenridge says it has an aggressive product development program and looks forward to adding more products to its ANDA portfolio during 2007.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.